August 21, 2019August 21, 2019

Eli Lilly Launches Challenge for Digital Solutions to Improve IBD Care

News

The pharmaceutical company Eli Lilly has announced an open innovation challenge for individuals, teams, and organizations in the United States to propose digital health solutions that can improve care for ... Read more

July 24, 2019July 24, 2019

Innovation and Alfasigma Ink Pact to Develop and Commercialize Brilacidin for Types of IBD

News

Innovation Pharmaceuticals now has a global licensing agreement with Alfasigma for the development and commercialization of the therapy Brilacidin for treating ulcerative proctitis/ulcerative proctosigmoiditis (UP/UPS), types of inflammatory bowel disease (IBD). ... Read more